Cellectar Biosciences, Inc.
- Biotech or pharma, therapeutic R&D
Cellectar Biosciences is developing phospholipid drug conjugates (PDCs). These monomeric lipid mimetics are designed to provide cancer targeted delivery. We utilize the metabolic change in cancer cells to create the specificity.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}